News
| Feb 02 | CARDIUM THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and... |
| Jan 30 | Cardium Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum PR Newswire |
| Jan 17 | Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Ral... |
| Jan 11 | $CXM has hit brickwall at $0.40 by CaptainOyama |
| Jan 10 | CARDIUM THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and... |
| Jan 09 | Smaller retail chasing $cxm Repeat of low volume bounce in Nov? by TCAdvisors |
| Jan 08 | will $CXM fly this week...here's hoping so by CaptainOyama |
| Jan 06 | CARDIUM THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and... |
| Jan 06 | Cardium Regains Listing Compliance With NYSE Amex Benzinga |
| Jan 05 | Cardium Announces First International Marketing and Distribution Agreement for Commer... |
| Dec 07 | when the f is $cxm gonna come out with news by harry624 |
| Nov 30 | What I am watching $BWEN $AMWI $BAC $MRNA $CXM $TRID by geoffg8 |
Profile
Exchange: AMEX Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cardium Therapeutics is down N/A over the last year vs S&P 500 Total Return up N/A, Reliv' International down N/A, and Insmed down N/A.
- CXM Total Returns
- ^SPXTR Total Returns
- RELV Total Returns
- INSM Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CXM related companies
Pro Strategies Featuring CXM
Did Cardium Therapeutics make it into our Pro Portfolio Strategies?
CXM Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other CXM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CXM | 0.38 | 0.00 | 1.02% | 31.17M |
| TNA | 63.13 | 4.00 | 6.77% | |
| IHF | 62.85 | 0.17 | 0.27% | |
| SKF | 46.76 | -2.36 | -4.80% | |
| AFK | 29.24 | 0.46 | 1.58% | |
| VE | 12.46 | 0.34 | 2.81% | 6.22B |
| RIMM | 16.88 | -0.33 | -1.92% | 8.85B |
| BCS | 15.10 | 0.68 | 4.72% | 47.58B |
| WFC | 30.63 | 0.73 | 2.44% | 161.53B |
| SRS | 30.58 | -0.96 | -3.04% |
